N/A
N=130
Staging and Outcome Depending on Surgical Treatment in Adenocarcinomas of the Oesophagogastric Junction
Esophageal Carcinoma
Bottom Line
View on ClinicalTrials.gov: NCT01766986 ↗Enrolled (actual)
130
Serious AEs
0.0%
Results posted
Jan 2021
Primary outcome: Primary: Overall Survival — 12; 11; 13 participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Primary completion
- Jan 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Overall Survival |
12; 11; 13 | — |
Summary
Background: Owing to controversial staging and classification of adenocarcinoma of the oesophagogastric junction (AOG) before surgery, the choice of appropriate surgical approach remains problematic.
In a retrospective study, preoperative staging of AOG and the impact of preoperative misclassification on outcome were analysed. Methods: Data from patients with AOG were analysed from a prospectively collected database with regard to surgical treatment, preoperative and postoperative staging, and outcome.
Eligibility Criteria
Inclusion Criteria
- One-hundred and thirty patients with Siewert types I and II AOG who did not have neoadjuvant treatment were included in the study
Exclusion Criteria
- AOG type III
- no surgical resection
Data sourced from ClinicalTrials.gov (NCT01766986). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.